Ocera Therapeutics, Inc. Comprehensive Income
Ocera Therapeutics, Inc. reported Comprehensive Income of -$6.27 million for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-14.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2017-11-14
- Ocera Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2017-09-30 was -$6.27M.
- Ocera Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2017-06-30 was -$6.13M.
- Ocera Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2017-03-31 was -$6.68M.
- Ocera Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2016-09-30 was -$7.13M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 111 month |
|---|---|---|---|---|
| 2017-09-30 | -$6.27M 10-Q · filed 2017-11-14 | -$12.40M derived: sum of 2 quarters · filed 2017-11-14 | -$19.09M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | -$6.13M 10-Q · filed 2017-08-01 | -$12.82M 10-Q · filed 2017-08-01 | ||
| 2017-03-31 | -$6.68M 10-Q · filed 2017-05-09 | |||
| 2016-09-30 | -$7.13M 10-Q · filed 2017-11-14 | -$14.23M derived: sum of 2 quarters · filed 2017-11-14 | -$21.74M 10-Q · filed 2017-11-14 | |
| 2016-06-30 | -$7.10M 10-Q · filed 2017-08-01 | -$14.61M 10-Q · filed 2017-08-01 | ||
| 2016-03-31 | -$7.51M 10-Q · filed 2017-05-09 | |||
| 2015-09-30 | -$6.57M 10-Q · filed 2016-11-02 | -$12.79M derived: sum of 2 quarters · filed 2016-11-02 | -$19.42M 10-Q · filed 2016-11-02 | |
| 2015-06-30 | -$6.22M 10-Q · filed 2016-08-04 | -$12.85M 10-Q · filed 2016-08-04 | ||
| 2015-03-31 | -$6.62M 10-Q · filed 2016-05-03 | |||
| 2014-09-30 | -$6.61M 10-Q · filed 2015-11-05 | -$13.84M derived: sum of 2 quarters · filed 2015-11-05 | -$17.90M 10-Q · filed 2015-11-05 | |
| 2014-06-30 | -$7.22M 10-Q · filed 2015-08-10 | -$11.29M 10-Q · filed 2015-08-10 | ||
| 2014-03-31 | -$4.06M 10-Q · filed 2015-05-07 | -$85.55M 10-Q · filed 2014-05-13 | ||
| 2013-09-30 | -$7.40M 10-Q · filed 2014-11-13 | -$9.49M derived: sum of 2 quarters · filed 2014-11-13 | -$10.22M 10-Q · filed 2014-11-13 | |
| 2013-06-30 | -$2.09M 10-Q · filed 2014-08-13 | -$2.82M 10-Q · filed 2014-08-13 | ||
| 2013-03-31 | -$731.00K 10-Q · filed 2014-05-13 |